NCT02019147View on ClinicalTrials.gov

BiHiVE2 Study. The Investigation and Validation of Predictive Biomarkers in Hypoxic-ischaemic Encephalopathy.

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Hypoxic Ischaemic Encephalopathy (HIE)Asphyxia
Trial Locations (2)

00000

Cork University Maternity Hospital, Cork

Unknown

Karolinska University Hospital, Stockholm

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

lead

University College Cork

OTHER

NCT02019147 - BiHiVE2 Study. The Investigation and Validation of Predictive Biomarkers in Hypoxic-ischaemic Encephalopathy. | Biotech Hunter | Biotech Hunter